POC High-Sensitivity Troponin Safety & Effectiveness in 0-2 Hour Rapid Algorithm
For healthcare professionals in emergency care, enhancing patient outcomes hinges on the ability to make swift decisions, making time efficiency a crucial factor. This webinar will share insights from leading experts on the latest advancements in cardiac emergency care, particularly in the rapid diagnosis of suspected acute myocardial infarction. The session will feature in-depth discussions on the safety and effectiveness of a novel 0-2 hour diagnostic algorithm using high-sensitivity troponin assays. Attendees will benefit from practical advice on implementing point-of-care technology in their own clinical settings. The webinar also offers a unique opportunity to engage directly with two of the authors of key clinical trials through a live Q&A session.
For healthcare professionals in emergency care, enhancing patient outcomes hinges on the ability to make swift decisions, making time efficiency a crucial factor. This webinar will share insights from leading experts on the latest advancements in cardiac emergency care, particularly in the rapid diagnosis of suspected acute myocardial infarction. The session will feature in-depth discussions on the safety and effectiveness of a novel 0-2 hour diagnostic algorithm using high-sensitivity troponin assays. Attendees will benefit from practical advice on implementing point-of-care technology in their own clinical settings. The webinar also offers a unique opportunity to engage directly with two of the authors of key clinical trials through a live Q&A session.
Learning objectives
This is the first report of a 0-/2-h strategy derived and validated in a POC hs-cTn assay in whole blood.
With analytical and diagnostic performances already established for VTLi hs-cTnI assay, this publication showcases the safety and effectiveness of using a 0-2 h algorithm using point-of-care technology in prospective observational studies in the US & Australia.
Thoughts and advice on POC high sensitivity troponin adoption from Professor Louise Cullen and Dr. Fred Apple and Cullen consider the current challenges faced by the lab and the emergency department.
Who Should Attend?
- Emergency physicians
- Laboratory personnel
- Cardiologists
- Nurses
- Paramedics and EMTs
Speaker Information:
Professor Louise Cullen, MBBS (Hon), FACEM, PhD, University of Queensland Royal Brisbane and Women’s Hospital, Australia
Professor Cullen is a renowned expert in emergency medicine, with a particular focus on cardiac care. Based in Australia, she has made significant contributions to the development of diagnostic pathways in the emergency department. Her work has been instrumental in improving the rapid diagnosis and treatment of patients with suspected acute coronary syndrome.
Professor Fred Apple, PhD, DABCC, Co-Director Clinical & Forensic Toxicology Laboratory Hennepin Healthcare/Hennepin County Medical Center Principal Investigator.
Dr. Apple is a leading clinical chemist and researcher from the United States, renowned globally for his expertise in cardiac biomarkers and his contributions related to troponin assays. His research has shaped the understanding and implementation of high-sensitivity cardiac troponin assays, greatly influencing how acute myocardial infarction is diagnosed and managed in emergency settings.
Dr. Apple serves as a principal investigator at the Minneapolis Medical Research Foundation. He is a consultant to the Hennepin County Medical Examiner’s Office. In addition to his investigative research, Dr. Apple is a Professor at the University of Minnesota Department of Laboratory Medicine and Pathology. Dr. Apple also serves as an Associate Editor for the journal Clinical Chemistry and is a Fellow of the American College of Sports Medicine.